IL2 and neoplasm: The anti-tumor potential of several cytokines such as interleukin 2 (IL-2), interferon γ (IFN-γ), granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-12 and IL-18 have been evaluated for the treatment of canine melanoma patients.